|
Market Closed -
Nasdaq
00:00:00 24/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.5177 USD | -4.41% |
|
-11.38% | -39.31% |
| 10-14 | Ladenburg Thalmann Initiates Aprea Therapeutics at Buy With $2 Price Target | MT |
| 08-28 | Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.41% | -11.38% | -31.95% | -18.09% | -39.31% | -63.02% | -86.83% | - | - | 6.52M | |
| +2.41% | +0.29% | -10.89% | +15.78% | +59.66% | +39.41% | +73.38% | +3.89% | - | 64.69B | |
| -0.15% | +7.50% | -7.45% | -2.76% | +9.12% | +11.42% | +75.22% | +213.38% | +5,435.74% | 54.78B | |
| +0.57% | +4.60% | +11.00% | +15.29% | +17.48% | +7.71% | +100.57% | -15.80% | +256.35% | 53.49B | |
| +0.37% | +4.67% | +3.33% | +34.28% | +23.93% | +26.68% | +54.16% | +8.59% | +275.33% | 45.98B | |
| -1.21% | +2.32% | +4.65% | +15.87% | +24.30% | +21.50% | +126.83% | -2.53% | +1,035.05% | 42.94B | |
| -0.37% | +5.07% | -8.77% | -1.18% | +134.76% | +243.23% | +834.48% | +599.03% | - | 40.08B | |
| +0.05% | +0.21% | +9.58% | +9.46% | +12.77% | +18.06% | +48.50% | +9.22% | +166.77% | 33.52B | |
| +0.39% | -8.29% | -14.04% | +18.73% | +45.99% | +23.12% | +3.15% | -61.75% | - | 23.97B | |
| -0.38% | +5.68% | +16.12% | +40.75% | +30.44% | +38.39% | +29.86% | -11.42% | +137.34% | 23.67B | |
| -1.73% | +0.46% | -10.56% | -1.36% | -7.44% | -16.61% | -7.49% | -70.12% | - | 22.13B | |
| -1.76% | -2.99% | -20.74% | -12.65% | -46.34% | -41.51% | +266.95% | +244.87% | +564.22% | 20.39B | |
| +2.33% | +8.20% | +8.13% | +11.28% | +19.15% | +10.57% | +158.86% | +255.24% | +2,101.30% | 18.72B | |
| +1.68% | +15.07% | +17.94% | +52.43% | +73.14% | +75.28% | +99.99% | -18.51% | +332.36% | 16.49B | |
| +1.73% | +8.23% | +9.49% | +27.56% | +35.74% | +34.62% | +85.18% | -17.69% | +105.48% | 16.47B | |
| -1.19% | +3.70% | +10.95% | +16.54% | +47.23% | +66.66% | +224.60% | +198.34% | +471.06% | 15.99B | |
| +0.16% | +8.04% | +7.88% | -4.13% | - | - | - | - | - | 15.98B | |
| -1.28% | -6.83% | +0.43% | +2.20% | +173.78% | +155.82% | +346.24% | +1,376.69% | +747.45% | 14.75B | |
| -0.09% | +8.87% | +7.51% | +11.77% | +1.67% | +4.02% | -17.76% | -34.62% | +123.11% | 14.29B | |
| +3.13% | +0.90% | +3.73% | -8.04% | +20.40% | +9.92% | +538.11% | - | - | 14.03B | |
| Average | -0.02% | +2.75% | +0.32% | +11.19% | +33.50% | +35.01% | +155.47% | +157.46% | +903.97% | 27.62B | |
| Weighted average by Cap. | +0.27% | +3.21% | +0.47% | +12.95% | +36.84% | +40.85% | +159.09% | +123.58% | +1,226.96% |
- Stock Market
- Stocks
- APRE Stock
- Sector Aprea Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
